New Onset Type I Diabetes clinical trials

Explore recruiting new onset type i diabetes clinical trials.

Recruiting new onset type i diabetes studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

New Onset Type I Diabetes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 12-month, randomized, single-blind, placebo-controlled exposure-response study of TCD601 (siplizumab) in new onset type 1 diabetes patients (STRIDE)

Sweden, Belgium, Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

New Onset Type I Diabetes trials by city

New Onset Type I Diabetes in Toronto New Onset Type I Diabetes in Vancouver New Onset Type I Diabetes in Montreal New Onset Type I Diabetes in Calgary New Onset Type I Diabetes in Edmonton New Onset Type I Diabetes in Ottawa New Onset Type I Diabetes in Winnipeg New Onset Type I Diabetes in Quebec City New Onset Type I Diabetes in Hamilton New Onset Type I Diabetes in Kitchener New Onset Type I Diabetes in London New Onset Type I Diabetes in Halifax New Onset Type I Diabetes in New York New Onset Type I Diabetes in Los Angeles New Onset Type I Diabetes in Chicago New Onset Type I Diabetes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease